Advertisement

Genetic Diseases

  • Herbert B. Allen
Chapter
  • 882 Downloads

Abstract

Many dermatologic diseases have a genetic component, and so this group of diseases may be expanded as more evidence is unearthed. Atopic dermatitis, for instance, is currently included in the dermatitis/eczema group. Filaggrin gene defects have been found in approximately 50% of the patients with atopic dermatitis, but the relationship of this defect to the pathogenesis of this disease has yet to be explained. Psoriasis also likely has a genetic background, but the story is not as well advanced as in atopic dermatitis.

Fabry disease, with the cutaneous finding of angiokeratomas, has the keyword “Maltese cross,” referring to the peculiar pattern seen in the urine under fluorescence microscopy. The angiokeratomas, although very descriptive, may be found in other disorders such as Klippel–Trenaunay–Weber syndrome and are found routinely on the scrotum of elderly men (Fordyce type). ­Angiokeratomas of Mibelli are solitary lesions found most commonly on the extremities. Fabry disease generally is recognized when the angiokeratoma clusters are seen on the abdomen, buttocks, or legs; they are part of a systemic disease with manifestations in other organs such as the kidneys, liver, or heart. Thus, they are an important marker for this systemic disease that results from an accumulation of ceramides in the affected organs. The genetic defect in α-galactosidase results in this accumulation.

Keywords

Maltese cross Plate-like scale Dirty scale Ash leaf shagreen patch Koenen tumor First trigeminal port-wine stain Coast of California Coast of Maine Werewolf Coumadin Plucked chicken skin Bamboo hair double-track scale Kinky hair Cupid’s bow Speckled hyperpigmentation 

References

  1. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A: replacement therapy in Fabry’s disease. N Engl J Med. 2001;345:9-16.Google Scholar
  2. DiGionanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis and management. Am J Clin Dermatol. 2003;4:81-95.CrossRefPubMedGoogle Scholar
  3. Elliott ST. X-linked ichthyosis: a metabolic disease. J Am Acad Dermatol. 1979;1:139-143.CrossRefPubMedGoogle Scholar
  4. Kandt RS. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases [review]. Neurol Clin. 2003;21:983-1004.CrossRefPubMedGoogle Scholar
  5. Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge-Weber syndrome: a review. Pediatr Neurol. 2004;30:303-310.CrossRefGoogle Scholar
  6. Barbagallo JS, Kolodzieh MS, Silverberg NB, Weinberg JM. Neuro­cutaneous disorders. Dermatol Clin. 2002;20:547-560, viii.CrossRefPubMedGoogle Scholar
  7. Bhansali A, Sharma BS, Sreenivasulu P, et al. Acromegaly with fibrous dysplasia: McCune-Albright Syndrome – clinical studies in 3 cases and brief review of literature–. Endocr J. 2003;50:793-799.CrossRefPubMedGoogle Scholar
  8. Murphy GM. Diagnosis and management of the erythropoietic ­porphyrias. Dermatol Ther. 2003;16:57-64.CrossRefPubMedGoogle Scholar
  9. Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg. 2000;87:266-272.CrossRefGoogle Scholar
  10. Pulkkinen L, Ringpfeil F, Uitto J. Progress in heritable skin diseases: ­molecular bases and clinical implications. J Am Acad Dermatol. 2002;47:91-104.CrossRefPubMedGoogle Scholar
  11. Cheng A, Bayliss S. The genetics of hair shaft disorders. J Am Acad ­Dermatol. 2008;59:1-21.CrossRefPubMedGoogle Scholar
  12. Kodama H, Murata Y, Kobayashi M. Clinical manifestations and treatment of Menkes disease and its variants. Pediatr Int. 2002;41:423-429.CrossRefPubMedGoogle Scholar
  13. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90-100.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2010

Authors and Affiliations

  • Herbert B. Allen
    • 1
  1. 1.Drexel University College of MedicinePhiladelphiaUSA

Personalised recommendations